Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7

Since the approval of imatinib in 2001, kinase inhibitors have revolutionized cancer therapies. Inside this family of phosphotransferases, casein kinase 2 (CK2) is of great interest and numerous scaffolds have been investigated to design CK2 inhibitors. Recently, functionalized indeno[1,2-b]indoles...

Descripción completa

Detalles Bibliográficos
Autores principales: Nacereddine, Abdelhamid, Bollacke, Andre, Róka, Eszter, Marminon, Christelle, Bouaziz, Zouhair, Fenyvesi, Ferenc, Bácskay, Ildikó Katalin, Jose, Joachim, Perret, Florent, Le Borgne, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874706/
https://www.ncbi.nlm.nih.gov/pubmed/29373552
http://dx.doi.org/10.3390/ph11010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874706/
https://www.ncbi.nlm.nih.gov/pubmed/29373552
http://dx.doi.org/10.3390/ph11010010

Ejemplares similares